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Abstract: 
Objective: To determine the frequency of impaired fasting blood glucose in healthy obese first degree relatives of 
type-2 diabetes mellitus patients. 
Methodology: This cross sectional study was conducted at Medical department of Liaquat University Hospital, 
Jamshoro over a period of six months. A total of 152 first degree relatives of type-2 diabetes mellitus patients, who 
were 18 years or older, having a BMI >25kg/m2 were included. Known diabetic individuals, having any other 
endocrine disorders, pregnant women and women with polycystic ovarian disease were excluded. Fasting blood 
glucose between 100-126 mg/dL was labeled as Impaired Fasting Glucose.  
Results: 60.5% (n= 92) of the sample comprised of males while 39.5% (n= 60) comprised of females. Female to 
male ratio was 1:1.53. The mean ± SD age was 29.92 ± 8.33 years with a range from 18 to 45 years. The mean ± SD 
BMI was 31.68 ± 3.31 Kg/m2 while mean ± SD FBS was 88.92 ± 16.33mg/dL. FBS ranged from 60 to 162 mg/dL.  
The frequency of impaired fasting glucose in healthy obese first degree relatives of type-2 diabetic Patients was 
13.2% (n = 20) [Odds ratio = 1.61, with 95% confidence interval of 7.82, 18.58].  
Conclusion: Diabetes mellitus (DM) is emerging as a major health-care challenge for Pakistan. The impaired 
fasting glucose (IFG) is frequent in healthy obese first degree relatives of type-2 diabetic patients.  
Recommendations: Proper and regular screening programmes are strongly recommended in this regard using the 
tests which are highly specific and sensitive. 
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INTRODUCTION: 
Diabetes mellitus is a group of metabolic diseases 
characterized by hyperglycemia resulting from 
defects in insulin secretion and/or insulin action and 
it is the third most common cause for morbidity and 
mortality [1]. Modernization has resulted in increased 
rate of diabetes, primarily because of a decrease in 
physical activity and an increase prevalence of 
obesity. Impaired fasting glucose is strongly 
associated with family history of type II diabetes 
mellitus and obesity. Most people with IFG and IGT 
go on to develop type II diabetes within 10 years.  
Progression of IFG and IGT to type II diabetes can be 
controlled by life style modification like weight 
reduction, increasing physical activity and restricting 
total calories.  
We consider familial aggregation of diabetes as a risk 
factor for the development of type II Diabetes 
Mellitus (type-2 DM), since family members (first 
degree relatives) not only share the genetic/hereditary 
factors involved in the etio-pathogenesis of DM, but 
also the socio-environmental and other risk factors 
(obesity, hyperlipidemia, hypertension, race-ethnic 
group), they constitute a high risk group. Thus, early 
diagnosis of type-2 DM is important so that diabetes 
related morbidity and mortality could be reduced. It 
will be possible to identify these high-risk subjects by 
screening for IFG and IGT [2]. 
Pakistan is 7th in the world according to latest 
estimates of prevalence of diabetes with 7-million 
peoples suffering from diabetes and by the year 2025, 
the country is expected to be 4th with 15 million 
peoples suffering from diabetes, representing a 2 fold 
increase in case load [3], efforts can be taken to 
reduce the onset of diabetes by knowing the fasting 
and glucose tolerance status in healthy obese first 
degree relatives of diabetes by recommending life 
style modification like weight reduction, diet 
intervention and regular exercise.   
The objective of this study id thus, to evaluate the 
prevalence of impaired fasting glucose for type II 
DM in first-degree relatives of known diabetic 
patients and highlight the impaired fasting glucose 
test to find out the incidence of DM [4-6]. 
  
MATERIAL AND METHODS: 
Study design:  
Cross sectional study. 
 
Setting:  
Medical departments of Liaquat University Hospital, 
Jamshoro. 
 
Duration: Six months. 
 
Sample size:  
Sample size calculated using Open-Epi Software. 
Confidence level (1-α %) was taken as 95%, with 
precision (d) of 0.05 and a power of 80%. Prevalence 
of impaired fasting glucose in anticipated population 
was taken 11.1 %.10 with an estimated sample size of 
152. 
 
Sample technique:  
Non-probability consecutive. 
 
Inclusion criteria: Individuals fulfilling the 
following inclusion criteria were included  
1. Individuals presenting at medical OPD for 
consultation regarding any health issue with 
a family history of type-2 diabetes mellitus 
in first degree relatives (father, mother, 
grandmother, grandfather, brother, sister, 
son and daughter). 
2. Individuals aged 18 years or above and 
having a BMI (body mass index) 25kg/m2 
and; 
3. A waist circumference >92 cms in males 
and >82 cms in females. 
Exclusion criteria: The following individuals were 
excluded from the sample 
1. Known diabetic individuals.  
2. Pregnant women. 
3. Individuals with any other endocrine 
disorders or known diagnosis of tumors, 
polycystic ovarian disease and any other 
disease with a potential risk of impaired 
glucose tolerance. 
 
Data collection procedure:  
Detailed medical history and physical examination 
was done for all the individuals who meet the 
inclusion criteria after taking informed consent. After 
a brief questionnaire based interview all participants 
were asked to follow for fasting blood sugar test. 
Blood samples were taken for overnight 8 hours 
fasting blood glucose, collected in test tube 
containing no preservative and were transported 
within half hour to Liaquat University Hospital 
laboratory to be examined using “PAP” enzymatic 
calorimetric test. Fasting blood glucose between 100-
126 mg/dL was labeled as Impaired Fasting Glucose. 
 
Data analysis:  
Data were analyzed on SPSS version 19 and 
Microsoft Excel. 
  
A p value of <0.05 was considered statistically 
significant. 
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RESULTS:  
Descriptive statistics (age, height, weight, BMI, waist circumference) are tabulated below. When evaluated for 
fasting blood sugar it was seen that mean ± SD FBS was 88.92 ± 16.33mg/dL. FBS ranged from 60 to 162 mg/dL. 
 
Table 1: The mean ± SD age of all the respondents (who were healthy obese first degree relatives of type-2 
diabetes mellitus patients) was 29.92 ± 8.33 years with a range from 18 to 45 years. (Table 1) The mean ± SD 
height was 144.85 ± 9.06 centimeters which ranged from 125 to 168 centimeters. The mean ± SD waist was 
38.78 ± 2.12 centimeters with a minimum waist of 34 and maximum waist of 45 centimeters. (Table 1)  The 
mean ± SD BMI of these healthy but obese individuals at time of inclusion in the study was 31.68 ± 3.31 
Kg/m2. Minimum BMI was 26.27 Kg/m2 while maximum BMI was 42.35 Kg/m2 
 
 Minimum Maximum Mean Std. Deviation 
Age (Years) 18 45 29.92 8.33 
Height (Centimeters) 15 168 144.85 9.06 
Height (meter2) 1.93 3.46 2.60 0.325 
Weight (KGs) 55 104 82.03 10.48 
BMI (weight by height in 
meters2) 
26.27 42.35 31.68 3.31 
Waist (Centimeters) 34 45 38.78 2.12 
Fasting Blood Sugar 
(mg/dL) 
60 162 88.92 16.33 
 
 
The primary outcome variable i-e; frequency of impaired fasting glucose in healthy obese first degree relatives of 
type-2 diabetic Patients was 13.2% (n = 20)  
 
Fig 1: frequency of impaired fasting glucose in healthy obese first degree relatives of type-2 diabetic Patients 
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Fig 2: Male respondents 
Male respondents were in majority. Males were 60.5% (n= 92) and females were 39.5% (n= 60).  
 
Almost half of respondents were of younger age group i-e; 18-25 years (42.1%; n= 64). Thirty six (23.7%) 
respondent were of age between 25-35 years while in age category 36 years and above; there were 34.2% (n = 52) 
respondents. 
 
 
 
Fig 3: Frequency of impaired fasting glucose in healthy obese first degree relatives of type-
2 diabetic patients increased with increasing age. Among youngest group (18-25 years) it 
was 10.9% which increased to 11.1% in 26-35 years age group and further upto 17.3% in 
eldest age group (36 years and above). This finding was not significant (P value = 0.551) 
 
 
Fig 2: Female to male ratio was 1:1.53. 
). 
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DISCUSSION: 
Diabetes is the most common endocrine disorder and 
the third most common cause for morbidity and 
mortality, following cardiovascular diseases and 
malignancies. According to International Diabetes 
Federation, the prevalence of diabetes is expected to 
increase from 5.9 % to 8.1%, by 2025 affecting more 
than 300 million people. The First International 
Congress on pre-diabetes and the Metabolic 
Syndrome was of the opinion that more than 50% of 
people with diabetes will come from Asia over the 
next decade. Such is the magnitude of diabetes [7, 8]. 
One of few strong risk factors for the development of 
type II Diabetes Mellitus (type2 DM) is genetics and 
familial aggregation. The American Diabetes 
Association recommends screening patients who are 
overweight or obese (BMI of 25 or higher) and who 
have additional risk factors for diabetes (Table A), 
such as family history of one or more first-degree 
relatives with type II diabetes [8]. Impaired fasting 
glucose test (IFG-T) has been recommended as an 
ideal way to screen this high-risk group. By early 
identification followed by preventive measures like 
exercise, diet, and good glycemic control the 
development of DM or its complications can be 
postponed.  
Putting this problem affront the current study was 
undertaken to evaluate the prevalence of impaired 
fasting glucose or type-2 DM in first-degree relatives 
of known type-2 diabetic patients and highlight the 
impaired fasting glucose test to find out the 
prevalence of glucose intolerance and DM.  
The population included in current study was 
younger with about half respondents of age between 
18 to 25 years. The mean age of all respondents was 
29.92 ± 8.33 years with a range from 18 to 45 years. 
A recent study [9] found that mean age (of obese 
healthy individuals, first degree relatives diabetes 
patients) was 43.1 ± 6.9 years. This difference from 
the current study findings was due to difference in the 
age limit of the Iranian study i-e; 30-60 years.  
In current study it was seen that male respondents 
were in majority. Female to male ratio was 1:1.53. 
No established evidence regarding increased 
susceptibility of any one gender for diabetes is 
available yet some studies found males while other 
reported female gender to be more prone to develop 
diabetes in case of a positive family history[10].  
The frequency of impaired fasting blood glucose 
among obese healthy first degree relatives of type-2 
diabetic patients was 13.2% [OR= 1.61; C.I. 7.82, 
18.58] in current study. The rate documented by 
other studies ranges from 9.8% to 35% [9, 11]. The 
results of current study are thus in concordance with 
international prevalence.   
Strengths of this study includes that it was first study 
to evaluate the risk of impaired fasting glucose in a 
high risk population in local context. The results of 
this study highlight the importance of screening of 
first degree obese relatives of type-2 diabetic patients 
who look and think themselves healthy otherwise. 
This will help in planning and implementing 
screening programs so as to early identify the 
potential undiscovered diabetes mellitus patients thus 
minimizing the morbidity and complications of 
diabetes mellitus.  
 
CONCLUSION: 
On basis of the results the study concludes that 
impaired fasting glucose is frequent in these 
populations at risk. Proper and regular screening 
programs are strongly recommended in this regard 
using the tests which are highly specific and 
sensitive. The current study warrants further research 
on the high risk people using continuous glucose 
monitoring system (CGMS) which is documented to 
be even better than OGTT in screening for diabetes 
mellitus type II. 
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